Northeast Pharmaceutical Group Co.,Ltd. Fundamental Rankings

This page is comprehensive fundamental data for Northeast Pharmaceutical Group Co.,Ltd.. Fundamentals are ordered by how Northeast Pharmaceutical Group Co.,Ltd. ranks compared to other companies (ordered high to low). All money values are in CNY. All data is powered by Quandl.

Cite in Wikipedia:

Indicator Value n/price Rank Date Historic
Construction materials163,078,9780.0453962015-06-30historic
Long term accounts payable1,002,863,0240.2791172015-06-30historic
Selling expenses337,432,9370.09391152015-06-30historic
Capital reserve1,769,921,9440.49258172015-06-30historic
Short term borrowings3,223,100,4130.89702172015-06-30historic
Cash from other investing activities325,000,0000.09045292015-06-30historic
Cash paid for other investing activities325,000,0000.09045312015-06-30historic
Intangible assets734,172,7950.20433362015-06-30historic
Other receivables287,988,4180.08015512015-06-30historic
Purchases of fixed assets and others217,842,5270.06063552015-06-30historic
Net cash and cash equivalents ending balance1,355,157,7720.37715602015-06-30historic
Cash inflows from financing activities2,577,274,6050.71728602015-06-30historic
Total non-current assets4,592,726,1721.27819742015-06-30historic
Total cost of goods sold2,201,139,6660.6126912015-06-30historic
Refunds of taxes25,149,2990.007932015-06-30historic
Cash paid for other financing activities125,185,1360.03484942015-06-30historic
Total liabilities and equity8,733,939,8712.43073962015-06-30historic
Financial expenses63,613,1410.0177982015-06-30historic
Accounts payable845,512,2880.23531982015-06-30historic
Revenue2,116,769,8660.58911992015-06-30historic
Total liabilities6,056,210,6671.685491042015-06-30historic
Fixed assets1,716,534,8660.477731192015-06-30historic
Notes receivable181,203,0480.050431202015-06-30historic
Other payables253,459,9750.070541432015-06-30historic
Diluted eps-00.01482015-06-30historic
Cash paid for dividends, profits or interests97,307,0200.027081492015-06-30historic
Inventories947,164,1630.26361572015-06-30historic
Cash from minority shareholders of subsidiaries1,000,0002.8E-41602015-06-30historic
Cash outflows from operating activities1,676,413,8050.466561632015-06-30historic
Cash inflows from operating activities1,553,590,7650.432381832015-06-30historic
Deferred tax assets33,943,5930.009452002015-06-30historic
Prepayment113,128,0890.031482232015-06-30historic
Non-operating loss1,242,8833.5E-42442015-06-30historic
Long term borrowings200,000,0000.055662642015-06-30historic
Minority interest99,170,0110.02762862015-06-30historic
Cash paid for taxes65,616,7150.018262902015-06-30historic
Comprehensive income attributable to minority shareholders1,701,3444.7E-43352015-06-30historic
Minority interests gain1,700,4514.7E-43392015-06-30historic
Other current assets46,865,5180.013044182015-06-30historic
Net cashflow from financing activities55,806,7240.015534912015-06-30historic
Payroll payable7,331,9850.002046852015-06-30historic
Net cash flows from investing activities-215,446,219-0.0599612152015-06-30historic
Net change in cash-282,486,575-0.0786213152015-06-30historic
Operating profit-81,973,492-0.0228113282015-06-30historic
Total comprehensive income-84,446,938-0.023513292015-06-30historic
Total profit-76,986,055-0.0214313292015-06-30historic
Net income-84,425,552-0.023513362015-06-30historic